Core Viewpoint - The National Medical Insurance Administration (NMIA) has optimized the classification of medical consumables, enhancing the standardization and precision of medical insurance management in China [1][5]. Group 1: Classification Optimization - The optimization focuses on seven categories of medical consumables, including vascular intervention stents and balloons, non-vascular intervention stents and balloons, anastomosis devices, artificial organs, and implantable cardiac rhythm management devices [1][5]. - The new classification aims to objectively reflect the functional characteristics of various consumables, addressing issues related to identification, differentiation, and management [1][3]. Group 2: Coding and Price Monitoring - The classification is based on the registration information from the medical device regulatory authority, grouping consumables with similar clinical uses and structures under the same category [2]. - The introduction of unified coding for medical consumables allows for precise price monitoring, helping to identify and correct unfair pricing practices [2][4]. Group 3: Support for Innovation and Clinical Needs - The revised classification supports innovation by adding new categories for products already registered with the regulatory authority but lacking appropriate classification in the medical insurance database [4]. - The optimization aligns with clinical needs, facilitating better management and application of medical consumables, particularly in areas with significant differences in clinical use and insurance payment values [4][3]. Group 4: Implementation and Impact - This revision marks the first nationwide implementation of unified coding for medical consumables, with the new database already operational in regions like Shanghai [5]. - The optimization is expected to enhance data-driven decision-making in medical insurance management, addressing questions related to affordability and value [3].

Core Viewpoint - The National Healthcare Security Administration (NHSA) of China has completed the classification optimization of seven categories of medical consumables, aiming to address issues related to identification, differentiation, and management, thereby enhancing the standardization and precision of medical insurance management [1][2]. Group 1: Classification Optimization - The classification optimization includes seven categories of medical consumables: vascular interventional stents, vascular interventional balloons, non-vascular interventional stents, non-vascular interventional balloons, surgical staplers, artificial organs, and implantable cardiac rhythm management devices [1]. - The optimization addresses the long-standing issue of inconsistent naming standards for medical consumables, which has complicated precise payment and fund supervision in medical insurance [1]. Group 2: Innovation and Industry Development - The classification adjustment supports innovation, exemplified by the separate categorization of leadless cardiac pacemakers, which represent a revolutionary technology in cardiac pacing, offering advantages such as minimally invasive implantation without incisions or leads [1]. - This adjustment provides more options for patients with traditional pacemakers who face complications such as multiple infections or lack of upper vena cava access [1]. Group 3: Implementation and Standardization - Under the guidance of the NHSA, regions like Shanghai have already implemented a new database for the seven categories of medical consumables, with other provinces accelerating their application of the new database [2]. - The establishment of a unified coding system for medical consumables is expected to standardize medical insurance business coding, data norms, and service processes, facilitating code-based bidding, procurement, and settlement [2].

Core Insights - The National Healthcare Security Administration (NHSA) has optimized the classification and generic names of seven categories of medical consumables, including vascular interventional stents, with full implementation of the related database expected by the end of September [1] Group 1: Medical Consumables Classification - The classification coding for medical consumables has been a challenging aspect of standardization in healthcare insurance [1] - The recent adjustments in classification coding aim to address long-standing issues of unclear categorization and complex management of medical consumables [1] - High-barrier technologies such as implantable cardiac rhythm management devices and artificial organs have been included in the new classification regulations, indicating a shift towards more detailed management in high-value areas [1] Group 2: Database and Future Plans - By August 2025, the medical consumables classification database is expected to publish 103,600 classification codes, covering 15,000 enterprises, 91,600 registration certificates, 140,900 products, and 13,379,600 specifications and models [1] - The NHSA plans to continue revising and optimizing the classification of other medical consumables, particularly allowing space for innovative products [1] - A temporary coding channel has been established under the "other" category in the medical consumables database to accommodate currently undefined innovative products [1]

Core Viewpoint - Jiangsu Province has issued policies to promote deep reforms in drug and medical device regulation, aiming to enhance the high-quality development of the pharmaceutical industry [1] Group 1: Support for Innovation - The policies emphasize support for the research and development of innovative products, focusing on areas such as innovation, clinical needs, and rare disease treatments [1] - A series of provincial science and technology projects will be implemented to support the development of cutting-edge medical technologies, including cell and gene therapy drugs, foreign-approved drugs, radioactive drugs, medical robots, and brain-computer interface devices [1] Group 2: Enhancement of Testing and Monitoring Capabilities - The initiative includes advancing the construction of testing platforms in emerging fields such as brain-computer interfaces and artificial organs [1] - The goal is to create advantageous testing projects in the field of medical acoustics [1]